Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06509815 · ClinicalTrials.gov registry record · NA

Multi-sensory Intervention Room Application (MIRA) Device in the NSICU

A NA study of Post-Intensive Care Syndrome, sponsored by Icahn School of Medicine at Mount Sinai.

Active
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT06509815 is a NA study of Post-Intensive Care Syndrome that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 34 participants, below the 188-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06509815, a NA study of Post-Intensive Care Syndrome, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to determine the safety, feasibility, and efficacy of a device, MIRA, on the physical, mental, and cognitive health of Neurosciences Intensive Care Unit (NSICU) patients. The study device is a Multi-Sensory Stimulation Device named MIRA, which uses commercially available hardware and builds off the SOLUNA software created by Studio Elsewhere, which produces audio and visual immersive experiences. The current device, Model M1, is a prototype developed for sole investigational purposes of this study and is not commercially available. Participants, who will be patients and staff of the NSICU, will complete questionnaires regarding safety, feasibility, and efficacy. The research team will enroll 20 patient and 15 staff participants. The trial is expected to last 12 months.

Conditions Studied

Post-Intensive Care Syndrome

Interventions

  • DEVICE MIRA

Study Locations (1)

New York

  • Mount Sinai Hospital - New York

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2024-08-25
Est. Completion 2026-01
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06509815

The ClinicalTrials.gov registry entry for NCT06509815 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (82% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Intensive Care Syndrome appearing as the primary indexed condition, and to 1 intervention - of which MIRA is the first listed.

NCT06509815 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06509815 about?

NCT06509815 is a clinical study titled "Multi-sensory Intervention Room Application (MIRA) Device in the NSICU". The purpose of this research study is to determine the safety, feasibility, and efficacy of a device, MIRA, on the physical, mental, and cognitive health of Neurosciences Intensive Care Unit (NSICU) patients. The study device is a Multi-Sensory Stimulation Device named MIRA, which uses commercially...

What is the current status of trial NCT06509815?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2024-08-25. Estimated completion is 2026-01.

What conditions does trial NCT06509815 study?

This clinical trial studies the following conditions: Post-Intensive Care Syndrome.

What interventions are being tested in trial NCT06509815?

The interventions under investigation include: MIRA (DEVICE).

Who is sponsoring clinical trial NCT06509815?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06509815 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post-Intensive Care Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post-Intensive Care Syndrome

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.